Manual manipulation and ex vivo flexible ureteroscopic lithotripsy to salvage deceased donor kidneys with renal stones: a case series

人工操作和体外软性输尿管镜碎石术挽救肾结石已故捐献者肾脏:病例系列

阅读:1

Abstract

BACKGROUND: Nephrolithiasis is generally considered a relative contraindication for kidney donation. This study aimed to evaluate the feasibility and effectiveness of a surgical technique designed to salvage deceased donor kidneys with renal stones. The technique involves manual manipulation of the recovered kidney combined with flexible ureteroscopic lithotripsy (MM-FURSL) to clear the stones prior to transplantation. CASE PRESENTATION: A total of nine kidneys were recovered from six deceased donors. The recipients (66.7% female; mean age 43.9 ± 12.2 years) had been on dialysis for an average of 2.6 years before undergoing renal transplantation with MM-FURSL. Donor kidneys contained 1 to 4 stones each, with a mean maximum stone diameter of 15.1 ± 10.6 mm and an average CT density of 942.0 ± 106.6 HU. The mean warm and cold ischemia times were 5 min and 480 ± 108.2 min, respectively. The average total operative duration was 57.0 ± 63.4 min. The first patient to undergo MM-FURSL had the longest operative and cold ischemia times due to the use of a reusable flexible ureteroscope, which was damaged during the procedure. She was the only patient to experience acute tubular necrosis (ATN), but her creatinine levels normalized within three weeks. No other complications were observed during a mean follow-up period of 11.7 ± 8.2 months. CONCLUSION: MM-FURSL is an effective method for removing renal stones in donor kidneys. Short-term outcomes were favorable, suggesting that this technique could be a viable approach to expand the donor pool by salvaging kidneys with nephrolithiasis. However, prolonged cold ischemia time may increase the risk of ATN and should be minimized.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。